BREAKING NEWS
President Signs Executive Order on Reducing Drug Shortages
On October 31, President Barack Obama signed an executive order directing the Food and Drug Administration (FDA) to take action to help further reduce and prevent shortages of prescription drugs, including shortages of many cancer medicines. For more information, see an FDA report and White House fact sheet on drug shortages.
NEWS
Organ Transplant Recipients Are at Increased Risk for a Range of Cancers
Patients who have received a solid organ transplant, such as a kidney, lung, or heart transplant, are twice as likely to develop cancer as the general population, and the risk extends to a broad range of cancers, according to research published November 1 in JAMA.
Doctors have known since the early days of organ transplantation that cancer is a possible complication of this often life-saving procedure. The new study gives researchers the first overview of cancer risk patterns in a large population of solid organ transplant recipients in the United States, including risk patterns for less common cancers. Read more > >
Annual Screening with Chest X-Ray Does Not Reduce Lung Cancer Deaths
Mortality risk did not drop even in higher-risk study participants, researchers sayRadiation Therapy after Breast-Conserving Surgery Improves Survival
Updated meta-analysis provides further support for radiation after surgeryTargeted Therapy Shows Benefit in Rare Type of Thyroid Cancer
FDA approved the drug earlier this year based on trial's initial findingsStudy Confirms Letrozole Prevents More Breast Cancer Recurrences than Tamoxifen
Long-term follow-up shows letrozole is better than tamoxifen or the two drugs given sequentiallyStudy Suggests Smaller Melanoma Excision Margins May Be Option for Some Patients
Survival rates the same in randomized trial comparing 2-cm and 4-cm marginsHPV Vaccine Reduces Anal HPV Infection and Precancerous Lesions
Vaccination may prevent precancers, for which no routine screening or treatment existAlso in the Journals: Low-Dose Nicotine Does Not Promote Lung Tumor Growth in Mice
Also in the Journals: Mobile Phones Do Not Raise Brain Cancer Risk
IN DEPTH
Study Shows Aspirin Reduces Colorectal Cancer in Those at High Risk
Those with Lynch syndrome may benefit from aspirin's anticancer effect
Tackling the Conundrum of Cachexia in Cancer
Research on the often devastating wasting condition shows signs of progress
Featured Clinical Trial: Cetuximab and Radiotherapy for HPV-Associated Oropharynx Cancer
Will substitution of cisplatin with cetuximab result in comparable 5-year overall survival?
UPDATES
CDC Update
- Committee Recommends Routine HPV Vaccination for Boys
- CDC Launches Initiative to Prevent Infections among Cancer Patients
Cancer.gov Update
- Recovery Act Funds Advances in Breast Cancer Detection, Treatment, and Prevention
- Online Education and Training for Health Professionals Now Easily Accessible
Notes
- NCI Recognizes 11 Clinical Investigators with Leadership Awards
- NCI Program Pairs Young Public Health Professionals with Mentors
- TCGA to Hold First Annual Scientific Symposium
- SEER Releases New U.S. Cancer Mortality Data, Cancer Statistics Review 2011
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
